NK cells and macrophages linked to milder tuberculosis lung damage

Tuberculosis remains the world’s deadliest infectious disease, and efforts to build better vaccines and treatments are held back by gaps in our understanding of protective immunity. Simone A. Joosten and colleagues set out to learn which local immune responses in the lung are associated with better control of Mycobacterium tuberculosis (Mtb). When people or animals are infected with Mtb, the immune system forms granulomas — organized aggregates of immune cells that surround the bacteria in the lung. These granulomas are a key battleground where the host tries to contain or kill the bacteria. The composition and local cellular environment inside a granuloma can strongly influence whether the bacteria are controlled or whether disease progresses. To search for immune features that correlate with protection, the research team analyzed archived lung tissue taken from non-human primates that had been infected with low doses of Mtb and had developed a range of disease severities. The goal was to identify which cells and cell-to-cell interactions in granulomas are linked to milder lung disease.

To map the cellular makeup of granulomas and how cells interact, the researchers used imaging mass cytometry on archived lung tissue from low dose Mycobacterium tuberculosis-infected non-human primates that presented with various levels of disease. Imaging mass cytometry is a technology that lets scientists visualize many different immune cell types in tissue while retaining spatial relationships between cells. Using this approach, the investigators compared granulomas from animals with limited lung pathology to those from animals with more severe disease. They found a clear correlation between granuloma composition and the severity of lung pathology. Specifically, granulomas from animals with limited disease were enriched for NK cells and showed increased interactions between NK cells and tissue macrophages. These NK cell–macrophage interactions were observed much more frequently in the better-controlled infection, suggesting a link between these local cellular interactions and reduced tuberculosis pathology.

The findings add a new layer to our understanding of how local immune interactions in the lung relate to control of tuberculosis. By pointing to NK cells and their interactions with macrophages inside granulomas as features of limited disease, the study provides specific cellular behaviors that might be considered when designing vaccines or host-directed therapies. The work also illustrates the value of studying tissue-level responses rather than only measuring immune cells in blood, because the granuloma environment appears to be a critical determinant of outcome. While further research will be needed to test whether enhancing NK cell–macrophage interactions can directly improve control of Mycobacterium tuberculosis, this study offers a concrete clue about what a protective local immune response might look like. That clue can help guide more focused experiments and, in time, inform strategies to develop improved vaccines and treatments for tuberculosis.